Denmark's equity market finished the session marginally lower on Friday, with sector-level weakness in Healthcare, Technology and Oil & Gas contributing to the overall decline. At the close in Copenhagen the OMX Copenhagen 20 lost 0.08%.
Among the index constituents, Pandora A/S (CSE:PNDORA) was the top performer, gaining 4.07% - a rise of 21.40 points - to finish at 547.40. Biotech group Genmab (CSE:GMAB) added 3.46% or 62.00 points to close at 1,853.50. Building materials firm Rockwool AS B (CSE:ROCKb) also advanced, up 2.64% or 6.00 points to 227.00 in late trade.
On the downside, ISS A/S (CSE:ISS) led losses among the larger names, slipping 3.03% or 7.40 points to end at 236.60. Novo Nordisk A/S Class B (CSE:NOVOb) fell 2.08% or 6.40 points to 301.00, while Vestas Wind Systems A/S (CSE:VWS) was down 0.06% or 0.10 points to 159.70.
Advancers outnumbered decliners on the Copenhagen Stock Exchange, with 73 stocks rising versus 41 falling; 21 issues finished unchanged. The breadth data show a market with more individual winners, even as the headline index was slightly into negative territory at the close.
Commodity markets moved modestly during the session. Crude oil for April delivery declined 0.39% or 0.26 to trade at $66.14 a barrel. Brent oil for April delivery mirrored that drop, falling 0.39% or 0.28 to $71.38 a barrel. Precious metals diverged, with the April Gold Futures contract rising 1.82% or 90.89 to trade at $5,088.29 a troy ounce.
Foreign exchange rates against the Danish krone were largely stable. USD/DKK was effectively unchanged, moving 0.03% to 6.34, while EUR/DKK was nearly flat, shifting 0.01% to 7.47. The US Dollar Index Futures was down 0.13% at 97.73.
These closing figures reflect a trading day in which select large-cap movers produced offsetting effects: strong gains in several names were balanced by declines among other heavyweight stocks, leaving the OMX Copenhagen 20 slightly negative by the session end.